Ranolazine for Angina in Hypertrophic Cardiomyopathy
Ranolazine is an antianginal and works by inhibiting late-sodium current (INaL). However, its use is limited mostly to patients with coronary artery disease. However, literature has shown its potential benefit in relieving angina in hypertrophic cardiomyopathy. Hereby, we discuss two cases where ran...
Saved in:
| Main Authors: | Akhtar Amin, Bernard Kim |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2018-01-01
|
| Series: | Case Reports in Cardiology |
| Online Access: | http://dx.doi.org/10.1155/2018/5142572 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
EVALUATION OF RANOLAZINE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND CHRONIC STABLE ANGINA. RESULTS FROM THE TERISA RANDOMIZED CLINICAL TRIAL (TYPE 2 DIABETES EVALUATION OF RANOLAZINE IN SUBJECTS WITH CHRONIC STABLE ANGINA)
Published: (2015-09-01) -
CASE OF DIAGNOSIS OF APICAL FORM OF HYPERTROPHIC CARDIOMYOPATHY WITH A PATIENT WITH PROGRESSIVE ANGINA CLINIC
by: N. S. Krylova, et al.
Published: (2015-01-01) -
RANOLAZINE IN ISCHEMIC HEART DISEASE
by: V. P. Lupanov
Published: (2015-12-01) -
Resolution of Angina Pectoris and Improvement of the Coronary Flow Reserve after Ranolazine Treatment in a Woman with Isolated Impaired Coronary Microcirculation
by: Alessandro Santoro, et al.
Published: (2013-01-01) -
A Rare Neurological Complication of Ranolazine
by: Jahan Porhomayon, et al.
Published: (2013-01-01)